FGF21 is also elevated in pathological conditions, such as obesity, insulin resistance, or liver diseases, and impairment in FGF21 signaling in these cases has also been described [43,141]. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.